Five Takeaways From The 2026 J.P. Morgan Healthcare Conference
The author Juergen Eckhardt, pictured center, speaking this week at a panel on medical innovation hosted by the…
Recursion Pharmaceuticals Rises as Positive Phase 1b/2 Trial Results for REC-4881 Validate AI-Driven Drug Discovery Platform
Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) is one of the most active US stocks to buy according to analysts. On…